Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 22.86 | N/A |
| PEG Ratio (TTM) | -4.95 | N/A |
| P/S Ratio (TTM) | 1.91 | N/A |
| P/B Ratio (TTM) | 0.72 | N/A |
| P/FCF Ratio (TTM) | 17.10 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.33% | N/A |
| ROE (TTM) | 3.19% | N/A |
| Net Profit Margin (TTM) | 7.34% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -1.58% | 105.87% | N/A |
| Revenue | 8.33% | 16.19% | N/A |
| Net Income | -4.22% | 101.73% | N/A |
| Cash Flow | 28.63% | 210.18% | N/A |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 170.65 | N/A |
| Quick Ratio (TTM) | 170.65 | N/A |
| D/E Ratio (TTM) | 0.95 | N/A |
| Interest Coverage (TTM) | 1.06 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.41 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |